Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

NCT: NCT04930289 · ENROLLING_BY_INVITATION

NCT IDNCT04930289
StatusENROLLING_BY_INVITATION
Start Date2021-10-15
Completion2029-12-30
SponsorParagonix Technologies (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patients

Frequently Asked Questions

What is Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs?

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs is a clinical trial registered under NCT04930289. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT04930289?

The current status of NCT04930289 (Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs) is: ENROLLING_BY_INVITATION.

When did Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs start?

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs started on 2021-10-15.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.